Autoclave Controller Software Meeting FDA 21 CFR Part 11 Guidelines Introduced
Oct 20 2017 Read 535 Times
Astell Scientific is pleased to announce the launch of a new software option that enables its full range of autoclaves to meet FDA 21 CFR Part 11 electronic signature regulations.
The software is targeted towards customers operating in the pharmaceutical and medical manufacturing industries, but can bring benefits to a much wider range of applications should traceability be of key importance when specifying a steriliser.
The basic requirement of the Electronic Records; Electronic Signature final rule (21 CFR 11) legislation is to ensure that any computerised system used for regulatory purposes produces electronic records that have integrity and reliability, and that electronic signatures are trustworthy and equivalent to handwritten signatures executed on paper records. Astell’s latest software combined with its advanced touchscreen controller positions the company as one of few autoclave manufacturers able to provide a solution that complies with FDA 21 CFR Part 11.
Available across both circular and square section sterilisers, the specially developed 21 CFR 11 controller software captures any change made to a cycle, option, or device parameter, which will require an electronic signature authorisation. All device changes and signatures will be electronically logged and can be recalled to provide a clear picture of user input for any given point in time. All audit trails are saved in a file format that cannot be altered in any way.
Astell spokesperson Dave Thomas commented: “The introduction of FDA compliant autoclave software offers our customers the transparency and record management required by tightly regulated industries. It’s another good reason to choose Astell Scientific, and demonstrates why we remain the leaders in sterilisation.”
For more information on Astell’s FDA 21 CFR Part 11 software option, its applications or capabilities please visit www.astell.com/21cfr11.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Choosing the Optimum Plasma Spectrochemistry Technique for Measuring Elemental Impurities in Pharmaceuticals - Monitoring Airborne Molecular Contamination in Indoo...
View all digital editions
Jun 27 2018 Tokyo, Japan
Jul 08 2018 Baltimore, MD, USA
Jul 29 2018 Chicago, IL, USA
Jul 29 2018 Washington DC, USA
Aug 05 2018 Baltimore, MD, USA